Original antigenic sin, possible vaccine shedding

zwez

Member
Joined
Oct 6, 2021
Messages
39
Location
New York
It appears people who get vaccinated never develop nucleocapsid antibodies to SARS-CoV-2. The fact that (S) spike protein antibodies do not prevent infection, death or hospitalization and they appear to prevent the development of (N) nucleocapsid antibodies means this disease may never go away for those who are vaccinated.

Original antigenic sin, also known as antigenic imprinting or the Hoskins effect,[1] refers to the propensity of the body's immune system to preferentially utilize immunological memory based on a previous infection when a second slightly different version of that foreign pathogen (e.g. a virus or bacterium) is encountered. This leaves the immune system "trapped" by the first response it has made to each antigen, and unable to mount potentially more effective responses during subsequent infections. Antibodies or T-cells induced during infections with the first variant of the pathogen are subject to a form of original antigenic sin, termed repertoire freeze.


There may also be clues in this report as to vaccine shedding induced spike (S) protein antibodies.
 

Attachments

  • E632F8B1-DECD-485D-9461-63A76F2F37F0.jpeg
    E632F8B1-DECD-485D-9461-63A76F2F37F0.jpeg
    159.5 KB · Views: 26

Don

Member
Joined
Sep 12, 2020
Messages
368
It appears people who get vaccinated never develop nucleocapsid antibodies to SARS-CoV-2. The fact that (S) spike protein antibodies do not prevent infection, death or hospitalization and they appear to prevent the development of (N) nucleocapsid antibodies means this disease may never go away for those who are vaccinated.




There may also be clues in this report as to vaccine shedding induced spike (S) protein antibodies.
what a nightmare thats been pulled over most of the world...............
 
OP
zwez

zwez

Member
Joined
Oct 6, 2021
Messages
39
Location
New York
This recent study seems to leave the authors perplexed as to why the majority of the vaccinated fail to develop (N) nucleocapsid antibodies.

Twenty-three participants reported a breakthrough infection post-vaccination, defined as PCR-confirmed SARS-CoV-2 infection ≥14 days after completion of vaccination (5). This represented 0.6% (23/4111) of all fully vaccinated participants in the study. All had received Pfizer vaccine (which was the vaccine received by most study participants). For these 23 participants, the median number of days between second vaccine dose and positive PCR was 30 days (IQR 25–50 days). Five (22%) had symptoms at the time of the positive PCR test and 18 (78%) did not have symptoms (they were tested as close contacts or as part of hospital outbreaks). All 23 participants had detectable anti-S antibodies, as expected post vaccination (6). Notably, only 6/23 (26%, 95%CI: 11–49) had detectable anti-N antibodies in response to their infection, compared to 663/812 (82%, 95%CI: 79–84, p-value= <0.001 (Chi-squared) of all participants in the study with previous PCR-confirmed infection having detectable anti-N antibodies. Of the 17 that were anti-N negative, median number of days between PCR positivity and sampling mid-point was 52 (range 9–67) so it is surprising that the majority of these had not mounted an anti-N antibody response (7). This low number of seroconversions might suggest that anti-N antibodies may be insensitive as a marker of natural infection post vaccination.
 

aliml

Member
Joined
Apr 17, 2017
Messages
692
UK Health Security Document Indicates That That N Antibody Levels Appear To Be Lower In Fully Vaccinated Individuals Who Acquire Infection!

 
EMF Mitigation - Flush Niacin - Big 5 Minerals

Similar threads

Back
Top Bottom